Marquis is the first FDA approved treatment for equine protozoal myeloencephalitis (EPM). Equine protozoal myeloencephalitis (EPM) is a common neurologic
Marquis (ponazuril) co. Marquis (ponazuril) is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by sarcocystis neurona.
MARQUIS for horses is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. EPM is one of the most common
Marquis, (ponazuril) from Bayer HealthCare, Animal Health, is now licensed in Canada as an oral coccidiocide for the treatment of EPM . Marquis
EPM Treatment Choose between Marquis, ParaNex-R, Protazil, or SarStart to treat and eliminate the symptoms of EPM.
Treat your horse's EPM with Marquis Antiprotozoal Oral Paste. Marquis is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by
Marquis (ponazuril) is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. DOSAGE: Marquis (15% w/w
Marquis (ponazuril) was the first FDA-approved medication available for EPM, and is still widely used. The most recent addition to this roster of EPM meds is a
EPM ; Marquis (ponazuril) Paste for EPM treatment from Boehringer Ingelheim. Marquis Paste. Boehringer Ingelheim ; Protazil. Merck ; ReBalance. PRN Pharmaca.
Comments